DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Reilmann R, McGarry A, Grachev ID. et al.;
European Huntington ʼs Disease Network; Huntington Study Group investigators. Safety and efficacy of pridopidine in patients with Huntington ʼs disease (PRIDE‑HD): a phase 2, randomised, placebocontrolled, multicentre, dose-ranging study.
Lancet Neurol 2019;
18: 165-176
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.